P1vital Limited   Report issue

For profit Phase 1 Phase 4
Founded: Wallingford United Kingdom (2004)

Organization Overview

First Clinical Trial
2010
NCT01101685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

P1vital Limited

Active Ingredients

Drugs in Phase 4 Trials (4)

escitalopram (lexapro) (1 trial)

ketamine (ketalar) (1 trial)

risperidone (risperdal) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (2)

htl0009936 (1 trial)

sdi-118 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Depressive Disorder, Major (Phase 4)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6